5th Jan 2011 16:36
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 31 December 2010, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares and American Depository Shares (ADSs) in the Company through the annual reinvestment of dividends paid throughout 2010:
GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award - Annual Dividend Reinvestment
Non-Executive Director | No. of Ordinary Shares | Average Price (£) | No. of ADSs | Average Price ($) |
Sir Christopher Gent | 2,658.67 | 12.55 |
|
|
Prof Sir Roy Anderson | 300.96 | 12.55 |
|
|
Dr Stephanie Burns |
|
| 268.56 | 39.18 |
Mr Lawrence Culp |
|
| 958.86 | 39.18 |
Sir Crispin Davis | 2,176.24 | 12.55 |
|
|
Sir Deryck Maughan |
|
| 851.96 | 39.18 |
Mr James Murdoch | 131.45 | 12.55 |
|
|
Dr Daniel Podolsky |
|
| 429.75 | 39.18 |
Mr Tom de Swaan | 469.75 | 12.55 |
|
|
Sir Robert Wilson | 613.37 | 12.55 |
|
|
The Company and the Non-Executive Directors were informed of these allocations on 4 January 2011.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
5 January 2011
Related Shares:
Glaxosmithkline